Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Cardiothoracic and Vascular Anesthesia Année : 2017

Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor

Résumé

Antiplatelet agents have a predominant role in the therapeutic treatment of acute coronary syndrome (ACS) and myocardial infarction. Recently, ticagrelor has been incorporated in the European Society of Cardiology guidelines for the management of ACS with ST elevation and non-ST elevation.1 The AHA/ACC guidelines further advocate the choice of ticagrelor over clopidogrel in patients with ACS with non-ST elevation treated with an early invasive strategy.2 In fact, major studies have proven the benefits of ticagrelor on cardiovascular death, myocardial infarction, and stroke without an increase in major bleeding risk
Fichier non déposé

Dates et versions

hal-01600698 , version 1 (02-10-2017)

Identifiants

Citer

Laura Filaire, D. T. Pham, Nicolas d'Ostrevy, Huyen T Tran, Lionnel Camilleri, et al.. Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor. Journal of Cardiothoracic and Vascular Anesthesia, 2017, in press (5), ⟨10.1053/j.jvca.2017.02.180⟩. ⟨hal-01600698⟩
114 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More